A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
NeurAxis, Inc. (NYSE American: NRXS) is a medical technology company focused on neuromodulation therapies for chronic and debilitating conditions affecting children and adults. The company's proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS)...
NeurAxis, Inc., (NYSE American: NRXS) is a medical technology company focused on neuromodulation therapies to address chronic and debilitating conditions in children and adults. This company webcast was recorded during the Lytham Partners 2026 Investor Healthcare...
NeurAxis, Inc. (NYSE American: NRXS) is a medical technology company focused on neuromodulation therapies to address chronic and debilitating conditions in children and adults. This fireside chat was recorded during the Lytham Partners Fall 2025 Investor Conference.
NeurAxis, Inc. (NYSE American: NRXS) is a medical technology company focused on neuromodulation therapies to address chronic and debilitating conditions in children and adults. This company webcast was recorded during the Lytham Partners Spring 2025 Investor...
This company webcast features NeurAxis, Inc. (NYSE American: NRXS). NeurAxis is a medical technology company focused on neuromodulation therapies to address chronic and debilitating conditions in children and adults. This company webcast was recorded during the Lytham...
NeurAxis, Inc. (NYSE American: NRXS) is a medical technology company focused on neuromodulation therapies to address chronic and debilitating conditions in children and adults. NeurAxis is dedicated to advancing science and leveraging evidence-based medicine to drive...
During this presentation, we welcome NeurAxis, ticker symbol NRXS on the NYSE American. Joining us today from the company is Brian Carrico, Chief Executive Officer. NeurAxis, Inc., is a medical technology company focused on neuromodulation therapies to address chronic...